The future of continuous downstream processing: A conversation with Biogen Idec and GE Healthcare Li

Time:December 03-03, 2014

Organizer:LabRoots, Inc.

Start: Dec, 03 2014 End: Dec, 03 2014

Join us for a webcast, three event times:

Wednesday, December 3, 2014.

Beijing (CST) 3:00 pm

Stockholm (CET) 11:00 am

New York (EST) 1:00 pm

Overview

The increasing pressures from global competition plus the need to reduce manufacturing costs are driving the biopharmaceutical industry to improve operational excellence in development and manufacturing. Continuous

downstream processing offers distinct advantages, but its adoption has been slow due to higher process complexity. Recent technological advancements are beginning to reduce these barriers to the integration of

continuous downstream processing Attend this webcast and learn about:

• Innovations such as periodic counter-current chromatography (PCC), which drive the adoption of continuous downstream processing

• Case studies featuring key lessons from the comprehensive evaluation of continuous downstream processing in monoclonal antibody development

• The next generation of biomanufacturing facilities

There will be a live Q&A session with continuous downstream processing experts from Biogen Idec and GE Healthcare.

Contact:Yorba Linda

Tel:1-714-926-6384

Fax:1-714-463-4673

E-mail:partners@labroots.com

Previous:Tumour Models London 2014

Next:The Development & Manufacturing of Vaccines Conference